[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
[ Thu, Oct 12th 2023 ]: WOPRAI
John Sourbeer Maintained (AKYA) at Strong Buy with Decreased Target to $7 on, Oct 12th, 2023
- 🞛 This publication is a summary or evaluation of another publication
John Sourbeer of UBS, Maintained "Akoya Biosciences, Inc." (AKYA) at Strong Buy with Decreased Target from $12 to $7 on, Oct 12th, 2023.
John has made no other calls on AKYA in the last 4 months.
There are 2 other peers that have a rating on AKYA. Out of the 2 peers that are also analyzing AKYA, 0 agree with John's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with John
- Mason Carrico of "Stephens & Co." Reiterated at Buy and Held Target at $16 on, Tuesday, August 8th, 2023
- Tejas Savant of "Morgan Stanley" Maintained at Buy with Decreased Target to $15 on, Tuesday, August 8th, 2023